For the year ending 2025-12-31, PHGE made -$3,162K in revenue. -$36,199K in net income. Net profit margin of 1144.81%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development (r&d) expenses, net | 21,292 | |||
| General and administrative expenses | 9,628 | |||
| Gain from early lease termination | 2,949 | |||
| Ipr&d impairment | 11,842 | |||
| Other long-lived assets impairment | 1,653 | |||
| Operating loss | -41,466 | |||
| Other expense (income) | -93 | |||
| Interest expenses | 20 | |||
| Finance expense , net | -724 | |||
| Income from change in fair value of warrants | -6,111 | |||
| Loss before tax | -36,192 | |||
| Tax expenses | 7 | |||
| Net loss | -36,199 | |||
| Basic loss per share of common stock (in dollars per share) | 22.19 | |||
| Diluted loss per share of common stock (in dollars per share) | 22.19 | |||
| Weighted average number of shares used in computing basic loss per share of common stock (in shares) | 1,631,037 | |||
| Weighted average number of shares used in computing diluted loss per share of common stock (in shares) | 1,631,037 | |||
BiomX Inc. (PHGE)
BiomX Inc. (PHGE)